Martin Quibell

No open positions remaining

Health Technology

Consumer Services

Profile

Martin Quibell is the founder and Chief Scientific Officer at Pedanius Therapeutics Ltd. which is founded in 2018.
He previously held positions as Director-Medicinal Chemistry at Acambis Plc, Vice President-Medicinal Chemistry at Amura Holdings Ltd. and Amura Therapeutics Ltd., and Principal at Incenta Ltd. Dr. Quibell earned a doctorate degree from the University of Birmingham in 1991 and an undergraduate degree from the University of Portsmouth.

Former positions of Martin Quibell

Companies	Position	End
Incenta Ltd.	Corporate Officer/Principal	-
Amura Therapeutics Ltd.	Corporate Officer/Principal	-
Acambis Plc Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines	Corporate Officer/Principal	-
Amura Holdings Ltd. Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Offers therapeutic drug research and development	Chief Tech/Sci/R&D Officer	-

See the detail of Martin Quibell's experience

Training of Martin Quibell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Quibell's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Acambis Plc Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines	Health Technology
University of Birmingham University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Portsmouth University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Amura Holdings Ltd. Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Offers therapeutic drug research and development	Health Technology
Amura Therapeutics Ltd.
Incenta Ltd.